AirSculpt Technologies, Inc. (AIRS) vs Korsana Biosciences, Inc. (KRSA)
A side-by-side comparison of AirSculpt Technologies, Inc. and Korsana Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AIRS
AirSculpt Technologies, Inc.
$1.89HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
KRSA
Korsana Biosciences, Inc.
$30.80HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
Total return — AIRS vs KRSA
growth of $100 · dividends reinvested · last 5yAIRS -87.4% (-34.0%/yr)KRSA -91.4% (-38.8%/yr)AIRS compounded faster over this window
AIRS KRSA
AIRS vs KRSA: by the numbers
- •KRSA is the larger company ($144M vs $133M market cap).
- •Both run net losses; AIRS's is the smaller (-7.79% vs -353.00% net margin).
- •AIRS grew revenue faster over the past five years (8.17% vs -11.98% CAGR).
Metrics side by side
Valuation
| Metric | AIRS | KRSA |
|---|---|---|
| P/S ratio | 0.88 | 75.89 |
| P/B ratio | 1.27 | 28.34 |
| EV / EBITDA | 435.24 | N/A |
| FCF yield | 0.57% | N/A |
Profitability
| Metric | AIRS | KRSA |
|---|---|---|
| Gross margin | 57.63% | 100.00% |
| Operating margin | -7.85% | -239.78% |
| Net margin | -7.79% | -353.00% |
| ROE | -11.20% | -131.85% |
| ROIC | -7.01% | -134.15% |
Growth (annualized)
| Metric | AIRS | KRSA |
|---|---|---|
| Revenue CAGR (5Y) | 8.17% | -11.98% |
| FCF CAGR (5Y) | -52.36% | N/A |
| Total return CAGR (5Y) | N/A | -40.41% |
Frequently asked
- Which has grown faster, AIRS or KRSA?
- Over the past five years, AIRS grew revenue faster — AIRS at a 8.17% CAGR versus KRSA at -11.98%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.